Inactive Instrument

Conpharm AB Share Price Swiss Exchange

CONP.B

SE0000102840

Real Estate Development & Operations

End-of-day quote Swiss Exchange
- ^SEK	-

01/09	Spotlight Value expands with five companies	FW
28/08	Slottsviken increased net asset value, CEO: sees value in investing in existing portfolio	FW

Analysts' recommendations: Conpharm AB

09/24/09	Affärsvärlden maintains its buy recommendation for Slottsviken after property acquisition	FW
27/23/27	Affärsvärlden maintains its buy recommendation for Slottsviken	FW
30/23/30	Affärsvärlden suggests seven interesting real estate shares	FW

More recommendations

Managers and Directors: Conpharm AB

Manager	Title	Age	Since
Jakob Österberg CEO	Chief Executive Officer	47	01/01/2013

Director	Title	Age	Since
Peter Hamnebo CHM	Chairman	49	01/01/2013
Jakob Österberg BRD	Director/Board Member	47	01/01/2013
Fredrik Lars Josef Österberg CHM	Chairman	51	01/01/2013

More insiders

Other Real Estate Development & Operations

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VINGROUP	-0.90%	+2.10%	+130.11%	+981.20%	7.17TCr
SUN HUNG KAI PROPERTIES LIMITED	-0.44%	-5.01%	+8.86%	+44.44%	4.18TCr
EMAAR PROPERTIES	-0.46%	+2.88%	-6.67%	+81.41%	3.11TCr
MITSUBISHI ESTATE CO., LTD.	+0.22%	+5.19%	+24.71%	+106.68%	3.01TCr
CHINA RESOURCES LAND LIMITED	-1.23%	-4.43%	-0.33%	+8.32%	2.85TCr
MITSUI FUDOSAN CO., LTD.	+0.94%	-0.03%	-5.79%	+45.49%	2.61TCr
CK ASSET HOLDINGS LIMITED	-0.16%	+0.57%	+19.50%	+29.15%	2.22TCr
DLF LIMITED	+3.59%	+3.23%	+1.06%	+26.04%	1.96TCr
VINHOMES	-0.48%	-1.74%	+32.34%	+194.09%	2TCr
Average	+0.11%	+1.56%	+22.65%	+168.54%	3TCr
Weighted average by Cap.	-0.16%	+1.80%	+38.39%	+289.99%

See all sector performances

Slottsviken Fastighetsaktiebolag (publ), formerly Conpharm AB (publ), is a Sweden-based company involved in real estate sector. The Company owns and manages residential, office and commercial properties in peri-urban locations. Slottsviken Fastighetsaktiebolag (publ) is a real estate company that acquires, manages and develops attractive properties in urban areas with a focus on the Gothenburg region. Its property portfolio includes residential properties; and commercial premises for production, shop/trade, restaurants, industry, workshops, logistics, and offices. The company also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities.

Employees

Sector

Real Estate Development & Operations

More about the company

Market Cap	5.16Cr 51.5L 46.57L 42.99L 38.91L 73.43L 48Cr 75.63L 2.05Cr 26Cr 1.93Cr 1.89Cr 82Cr	P/E 2024	23.1x	P/E 2025	28.8x
Enterprise Value	10Cr 1.03Cr 92.78L 85.64L 77.52L 1.46Cr 96Cr 1.51Cr 4.08Cr 52Cr 3.85Cr 3.77Cr 164.12Cr	EV / Sales 2024	8.35x	EV / Sales 2025	9.69x
Free-Float	83.79%	Yield 2024	0.3%	Yield 2025	0.3%

01/09	Spotlight Value expands with five companies	FW
28/08	Slottsviken increased net asset value, CEO: sees value in investing in existing portfolio	FW
27/08	Slottsviken Fastighetsaktiebolag Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
18/08	Five new companies join Spotlight Value	FW
27/05	Slottsviken shares trade ex-dividend today on Spotlight at SEK 0.12 per share	FW
19/05	Slottsviken's long-term net asset value edges higher in Q1	FW
19/05	Slottsviken Fastighetsaktiebolag Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
29/04	Slottsviken Fastighetsaktiebolag announces Annual dividend, payable on June 02, 2026	CI
26/02	Slottsviken Increases Dividend	FW
26/02	Slottsviken Fastighetsaktiebolag Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
24/11	Slottsviken Increases Net Asset Value in the Third Quarter	FW
21/11	Slottsviken Fastighetsaktiebolag Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
22/25/22	Slottsviken Improves Net Profit in Q2	FW

	2024	2025
Net sales	1.31Cr 13.05L 11.8L 10.9L 10L 18.61L 12Cr 19.17L 51.97L 6.56Cr 48.99L 47.95L 21Cr	1.35Cr 13.51L 12.22L 11.28L 10.21L 19.26L 13Cr 19.84L 53.78L 6.79Cr 50.7L 49.62L 22Cr
Net income	27.81L 3L 3L 2L 2L 4L 2.61Cr 4L 11.05L 1.39Cr 10.42L 10.2L 4.44Cr	27.82L 3L 3L 2L 2L 4L 2.61Cr 4L 11.06L 1.4Cr 10.42L 10.2L 4.44Cr
Net Debt	4.16Cr 41.57L 37.59L 34.7L 31.41L 59.26L 39Cr 61.04L 1.66Cr 21Cr 1.56Cr 1.53Cr 66Cr	5.12Cr 51.09L 46.2L 42.65L 38.6L 72.85L 48Cr 75.03L 2.03Cr 26Cr 1.92Cr 1.88Cr 82Cr

Conpharm AB Share Price Swiss Exchange

Stocks

CONP.B

SE0000102840

Real Estate Development & Operations

Valuation: Conpharm AB

Latest news: Conpharm AB

Analysts' recommendations: Conpharm AB

Managers and Directors: Conpharm AB

Other Real Estate Development & Operations

Financials

Company Profile